AI assistant
UNITED THERAPEUTICS Corp — Director's Dealing 2021
Jun 29, 2021
30320_dirs_2021-06-28_6bd5aef0-2533-41f6-9bae-8bffb73084be.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2021-06-26
Reporting Person: Klein Katherine J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-26 | Common Stock | M | 1680 | — | Acquired | 1680 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-26 | Restricted Stock Units | $0 | M | 1680 | Disposed | Common Stock (1680) | Direct |
Footnotes
F1: Shares received upon vesting of restricted stock units on June 26, 2021. Restricted stock units converted on a one-for-one basis into shares of common stock.
F2: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
F3: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.